Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 3
1997 8
1998 15
1999 11
2000 17
2001 21
2002 12
2003 12
2004 13
2005 8
2006 12
2007 18
2008 20
2009 16
2010 7
2011 20
2012 24
2013 16
2014 9
2015 2
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

250 results

Results by year

Filters applied: . Clear all
Page 1
The mutational landscape of lethal castration-resistant prostate cancer.
Grasso CS, Wu YM, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, Quist MJ, Jing X, Lonigro RJ, Brenner JC, Asangani IA, Ateeq B, Chun SY, Siddiqui J, Sam L, Anstett M, Mehra R, Prensner JR, Palanisamy N, Ryslik GA, Vandin F, Raphael BJ, Kunju LP, Rhodes DR, Pienta KJ, Chinnaiyan AM, Tomlins SA. Grasso CS, et al. Nature. 2012 Jul 12;487(7406):239-43. doi: 10.1038/nature11125. Nature. 2012. PMID: 22722839 Free PMC article.
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets.
Beltran H, Rickman DS, Park K, Chae SS, Sboner A, MacDonald TY, Wang Y, Sheikh KL, Terry S, Tagawa ST, Dhir R, Nelson JB, de la Taille A, Allory Y, Gerstein MB, Perner S, Pienta KJ, Chinnaiyan AM, Wang Y, Collins CC, Gleave ME, Demichelis F, Nanus DM, Rubin MA. Beltran H, et al. Cancer Discov. 2011 Nov;1(6):487-95. doi: 10.1158/2159-8290.CD-11-0130. Cancer Discov. 2011. PMID: 22389870 Free PMC article.
Prostate cancer biomarkers: a current perspective.
Kumar-Sinha C, Rhodes DR, Yu J, Chinnaiyan AM. Kumar-Sinha C, et al. Expert Rev Mol Diagn. 2003 Jul;3(4):459-70. doi: 10.1586/14737159.3.4.459. Expert Rev Mol Diagn. 2003. PMID: 12877385 Review.
Integrative biology of prostate cancer progression.
Tomlins SA, Rubin MA, Chinnaiyan AM. Tomlins SA, et al. Annu Rev Pathol. 2006;1:243-71. doi: 10.1146/annurev.pathol.1.110304.100047. Annu Rev Pathol. 2006. PMID: 18039115 Review.
Molecular markers of prostate cancer.
Bradford TJ, Tomlins SA, Wang X, Chinnaiyan AM. Bradford TJ, et al. Urol Oncol. 2006 Nov-Dec;24(6):538-51. doi: 10.1016/j.urolonc.2006.07.004. Urol Oncol. 2006. PMID: 17138135 Review.
Interleukin-6 and prostate cancer progression.
Smith PC, Hobisch A, Lin DL, Culig Z, Keller ET. Smith PC, et al. Cytokine Growth Factor Rev. 2001 Mar;12(1):33-40. doi: 10.1016/s1359-6101(00)00021-6. Cytokine Growth Factor Rev. 2001. PMID: 11312117 Review.
250 results